Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIb study of intratumoral para-toluenesulfonamide injection in advanced lung cancer
ChiCTR-ONC-12002942Phase 2Completed
- Sponsor
- The First Affiliated Hospital of Guangzhou Medical University
- Start
- Jul 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of para-toluenesulfonamide in bronchial carcinoma, sponsored by The First Affiliated Hospital of Guangzhou Medical University. Primary endpoints: Efficacy evaluation, Enhanced CT evaluation of tumor blood flow and 3 more. Started Jul 2005; status: completed.
02
Drugs
para-toluenesulfonamide
03
Conditions
bronchial carcinoma
Beyond the preview
Go deeper on ChiCTR-ONC-12002942.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-ONC-12002942.